Estrogen Metabolite Balancing refers to the clinical goal of optimizing the ratio between the catechol estrogen metabolites (2-OH-E1) and the less favorable or more potent metabolites (16-OH-E1) through modulation of metabolic enzymes.
Origin
This practice stems from functional endocrinology, focusing on the Phase I and Phase II detoxification pathways responsible for estrogen clearance in the liver and other tissues.
Mechanism
Achieving balance involves supporting enzymatic activity, such as Cytochrome P450 enzymes (e.g., CYP1A1, CYP1B1) and methylation processes, to favor protective estrogen pathways over potentially proliferative ones.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.